Literature DB >> 17052761

Respiratory viruses do not trigger meningococcal disease in children.

Kathryn A Dunlop1, Peter V Coyle, Paul Jackson, Christopher C Patterson, Michael D Shields.   

Abstract

OBJECTIVES: To determine whether the nasopharyngitis prodrome of meningococcal disease is caused by the disease itself or respiratory viral coinfection.
METHODS: Case control study of children with suspected meningococcal disease. Nasal swabs and a respiratory history were obtained from suspected cases and matched controls. Molecular testing for 12 respiratory viruses was used.
RESULTS: 104 suspected cases and controls were recruited. Detection rates for respiratory viruses were 27% (28/104) for suspected cases and 29% (30/104) for controls. Rhinoviruses (43/58, 74%) and adenoviruses (14/58, 24%) occurred most frequently with 3 coinfections. 39 (38%) suspected cases were confirmed as meningococcal disease with a detection rate for respiratory viruses of 26% (10/39). No significant difference was found in the respiratory viral detection rate between this group and their controls, Odds ratio=1.0 (95% CI 0.3 to 3.3). Prodromal respiratory symptoms were significantly more likely for suspected cases (77/104, 74%) than controls (55/104, 53%), Odds ratio 2.8 (95% CI 1.4 to 6.0), but were equally common in confirmed (28/39, 72%) and unconfirmed cases (49/65, 75%), Odds ratio 0.8 (95% CI 0.3 to 2.3).
CONCLUSIONS: This study found no evidence that respiratory viral infections contribute to the prodrome of meningococcal disease. Rhinovirus and adenovirus detection by nasal swab is common in well and unwell children.

Entities:  

Mesh:

Year:  2006        PMID: 17052761     DOI: 10.1016/j.jinf.2006.09.003

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  1 in total

1.  Fatal Pediatric Meningococcal Invasive Disease Caused by Neisseria meningitidis Serogroup C and Co-Infected With SARS-CoV-2: Report of a Case in Tijuana, Mexico.

Authors:  Enrique Chacón-Cruz; Erika Z Lopatynsky; Jesus R Machado-Contreras; Ricardo Gatica-Herrera; Oscar E Zazueta
Journal:  Cureus       Date:  2022-02-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.